Rally Foundation for Childhood Cancer Research Awards $5M in 2024 In 2024, Rally Foundation for Childhood Cancer Research (Rally) will...
Rally Awards Novel Grants to Three Childhood Cancer Researchers Rally Foundation for Childhood Cancer Research (“Rally”) awarded $150,000...
Rally Foundation for Childhood Cancer Research Awards $4 Million in 2023 In 2023, Rally Foundation for Childhood Cancer Research (“Rally”)...
Passion for Pediatric Cancer Patients and Research Drives Meaningful Discovery “Every day, I’m motivated to discover more through research...
Rally Foundation for Childhood Cancer Research Awards $3.4 Million in Grants This year, 51 researchers from 31 institutions across the...
Rally Foundation for Childhood Cancer Research (Rally) likes funding outside-the-box ideas and, at times, funding outside-of-the-box...
A key part of Rally’s mission is to find better treatments with fewer long-term side effects, and for almost a decade. Rally has invested...
Osteosarcoma (OS) is a type of cancer that begins in the cells that form bones, and mainly affects teenagers and young adults. In...
Rally is proud to be the initial funder for the creation of the INSTRuCT Database with a Consortium Grant to Dr. Sam Volchenboum of the...
Glioblastoma (GBM) in children and adults is a deadly brain tumor with a poor prognosis. Current treatment includes surgery to remove as...
Rally Foundation for Childhood Cancer Research Awards $5M in 2024 In 2024, Rally Foundation for Childhood Cancer Research (Rally) will award a total of $5 million to 74 researchers across 34 institutions worldwide – the largest number of childhood cancer research grants ever to be distributed since Rally was founded in 2005. “This brings the total amount of research funds that Rally has awarded to $35 million – and it is the highest amount we have been able to award in one year,” says Dean...
Rally Awards Novel Grants to Three Childhood Cancer Researchers Rally Foundation for Childhood Cancer Research (“Rally”) awarded $150,000 to three researchers at three different institutions for Outside the Box novel childhood cancer research ideas. “Rally sees itself as philanthropic seed investors in the next great discovery — we like to invest early and are willing to take risks because these Outside the Box ideas may pave the way to finding better treatments and cures,” says Dean Crowe,...
Rally Foundation for Childhood Cancer Research Awards $4 Million in 2023 In 2023, Rally Foundation for Childhood Cancer Research (“Rally”) will award a total of $4 million to 57 researchers across 30 institutions worldwide – the largest number of childhood cancer research grants ever to be distributed since Rally was founded in 2005. “This brings the total amount of research funds that Rally has awarded to $29.4 million – and it is the highest amount we have been able to award in one year,”...
Passion for Pediatric Cancer Patients and Research Drives Meaningful Discovery “Every day, I’m motivated to discover more through research that will enable us to better treat children with cancer and improve outcomes with fewer side effects.” Since his first lab job in the summer between his freshman and sophomore year in college, Adam D. Durbin, MD, PhD, of the Division of Molecular Oncology, Department of Oncology, St. Jude Children’s Research Hospital, has been fascinated by medical...
Rally Foundation for Childhood Cancer Research Awards $3.4 Million in Grants This year, 51 researchers from 31 institutions across the country and worldwide will receive a total of $3.4 million in grants from Rally Foundation for Childhood Cancer Research. “Rally Foundation has now awarded $25.4 million in grants for childhood cancer research since we started in 2005,” says Dean Crowe, Founder and CEO. “From the beginning, our mission has been to fund the best research wherever it may be to...
Rally Foundation for Childhood Cancer Research (Rally) likes funding outside-the-box ideas and, at times, funding outside-of-the-box researchers: those who we normally not consider as a scientific researcher. Rally is thrilled to share recent developments from an outside-the-box researcher and his study of Wilms’ Tumor. The study emerges from the Children’s Cancer Therapy Development Institute (cc-TDI) in Beaverton, Oregon, in collaboration with Memorial Sloan Kettering Cancer Center....